[Sentinel lymph node biopsy necessary in melanoma patients]

Area of Science:

• Oncology
• Surgical Oncology
• Dermatology

Background:

• Sentinel lymph node biopsy (SLNB) is a procedure to determine if melanoma has spread.
• Accurate staging is crucial for effective melanoma treatment and patient outcomes.

Purpose of the Study:

• To evaluate the prognostic value and impact of SLNB on melanoma patient survival.
• To assess the morbidity and quality of life associated with SLNB.

Main Methods:

• Review of findings from the only randomized study on SLNB in melanoma.
• Analysis of long-term survival data (10-year) stratified by nodal status and melanoma thickness.

Main Results:

• SLNB provides significant prognostic information and improves regional tumor control.
• The study demonstrated improved melanoma-specific survival at 10 years for node-positive patients with intermediate-thickness melanoma.
• Morbidity associated with SLNB is limited, with good subsequent quality of life.

Conclusions:

• SLNB is recommended as a standard diagnostic procedure for melanoma patients with intermediate-thickness, node-positive disease.
• Consideration of SLNB may be appropriate for patients with thinner or thicker melanomas based on clinical judgment.